Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostatic Artery Embolization Versus 532 nm Green Light Laser Photoselective Vaporization of the Prostate for Treating Catheter-Dependent Patients With Benign Prostatic Hyperplasia: A Randomized Controlled Clinical Study

NCT02006303 is registered in ClinicalTrials.gov with Royal Victoria Hospital, Canada as lead sponsor.

NCT NCT02006303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02006303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostatic Artery Embolization Versus 532 nm Green Light Laser Photoselective Vaporization of the Prostate for Treating Catheter-Dependent Patients With Benign Prostatic Hyperplasia: A Randomized Controlled Clinical Study
Lead sponsor
Royal Victoria Hospital, Canada
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2013
Completion date
December 31, 2015
Enrollment
73 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostate hyperplasia, urinary retention